FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964361983> ?p ?o ?g. }

• W1964361983 endingPage "e3089" @default.
• W1964361983 startingPage "e3089" @default.
• W1964361983 abstract "The World Health Organization (WHO) recommends that tuberculosis (TB) patients receive directly observed therapy (DOT). Randomized controlled trials have not consistently shown that this practice improves TB treatment success rates. In Thailand, one of 22 WHO-designated high burden TB countries, patients may have TB treatment observed by a health care worker (HCW), family member, or no one. We studied whether DOT improved TB treatment outcomes in a prospective, observational cohort.We prospectively collected epidemiologic data about TB patients treated at public and private facilities in four provinces in Thailand and the national infectious diseases hospital from 2004-2006. Public health staff recorded the type of observed therapy that patients received during the first two months of TB treatment. We limited our analysis to pulmonary TB patients never previously treated for TB and not known to have multidrug-resistant TB. We analyzed the proportion of patients still on treatment at the end of two months and with treatment success at the end of treatment according to DOT type. We used propensity score analysis to control for factors associated with DOT and treatment outcome. Of 8,031 patients eligible for analysis, 24% received HCW DOT, 59% family DOT, and 18% self-administered therapy (SAT). Smear-positive TB was diagnosed in 63%, and 21% were HIV-infected. Of patients either on treatment or that defaulted at two months, 1601/1636 (98%) patients that received HCW DOT remained on treatment at two months compared with 1096/1268 (86%) patients that received SAT (adjusted OR [aOR] 3.8; 95% confidence interval [CI] 2.4-6.0) and 3782/3987 (95%) patients that received family DOT (aOR 2.1; CI, 1.4-3.1). Of patients that had treatment success or that defaulted at the end of treatment, 1369/1477 (93%) patients that received HCW DOT completed treatment compared with 744/1074 (69%) patients that received SAT (aOR 3.3; CI, 2.4-4.5) and 3130/3529 (89%) patients that received family DOT (aOR 1.5; 1.2-1.9). The benefit of HCW DOT compared with SAT was similar, but smaller, when comparing patients with treatment success to those with death, default, or failure.In Thailand, two months of DOT was associated with lower odds of default during treatment. The magnitude of benefit was greater for DOT provided by a HCW compared with a family member. Thailand should consider increasing its use of HCW DOT during TB treatment." @default.
• W1964361983 created "2016-06-24" @default.
• W1964361983 creator A5008490774 @default.
• W1964361983 creator A5008795552 @default.
• W1964361983 creator A5031321809 @default.
• W1964361983 creator A5035498291 @default.
• W1964361983 creator A5054414805 @default.
• W1964361983 creator A5058196235 @default.
• W1964361983 creator A5058913702 @default.
• W1964361983 creator A5066427359 @default.
• W1964361983 creator A5067134812 @default.
• W1964361983 creator A5077092165 @default.
• W1964361983 creator A5078147497 @default.
• W1964361983 creator A5079092642 @default.
• W1964361983 date "2008-08-28" @default.
• W1964361983 modified "2023-10-06" @default.
• W1964361983 title "Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand" @default.
• W1964361983 cites W1996971859 @default.
• W1964361983 cites W2017719828 @default.
• W1964361983 cites W2034703556 @default.
• W1964361983 cites W2037513501 @default.
• W1964361983 cites W2052806549 @default.
• W1964361983 cites W2087264723 @default.
• W1964361983 cites W2103640382 @default.
• W1964361983 cites W2107176478 @default.
• W1964361983 cites W2125168028 @default.
• W1964361983 cites W2130718830 @default.
• W1964361983 cites W2155856528 @default.
• W1964361983 cites W2158936564 @default.
• W1964361983 cites W2161330753 @default.
• W1964361983 cites W2416968959 @default.
• W1964361983 cites W4210749876 @default.
• W1964361983 cites W4377077287 @default.
• W1964361983 doi "https://doi.org/10.1371/journal.pone.0003089" @default.
• W1964361983 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2518105" @default.
• W1964361983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18769479" @default.
• W1964361983 hasPublicationYear "2008" @default.
• W1964361983 type Work @default.
• W1964361983 sameAs 1964361983 @default.
• W1964361983 citedByCount "41" @default.
• W1964361983 countsByYear W19643619832012 @default.
• W1964361983 countsByYear W19643619832013 @default.
• W1964361983 countsByYear W19643619832014 @default.
• W1964361983 countsByYear W19643619832015 @default.
• W1964361983 countsByYear W19643619832016 @default.
• W1964361983 countsByYear W19643619832017 @default.
• W1964361983 countsByYear W19643619832018 @default.
• W1964361983 countsByYear W19643619832019 @default.
• W1964361983 countsByYear W19643619832020 @default.
• W1964361983 countsByYear W19643619832021 @default.
• W1964361983 countsByYear W19643619832022 @default.
• W1964361983 countsByYear W19643619832023 @default.
• W1964361983 crossrefType "journal-article" @default.
• W1964361983 hasAuthorship W1964361983A5008490774 @default.
• W1964361983 hasAuthorship W1964361983A5008795552 @default.
• W1964361983 hasAuthorship W1964361983A5031321809 @default.
• W1964361983 hasAuthorship W1964361983A5035498291 @default.
• W1964361983 hasAuthorship W1964361983A5054414805 @default.
• W1964361983 hasAuthorship W1964361983A5058196235 @default.
• W1964361983 hasAuthorship W1964361983A5058913702 @default.
• W1964361983 hasAuthorship W1964361983A5066427359 @default.
• W1964361983 hasAuthorship W1964361983A5067134812 @default.
• W1964361983 hasAuthorship W1964361983A5077092165 @default.
• W1964361983 hasAuthorship W1964361983A5078147497 @default.
• W1964361983 hasAuthorship W1964361983A5079092642 @default.
• W1964361983 hasBestOaLocation W19643619831 @default.
• W1964361983 hasConcept C126322002 @default.
• W1964361983 hasConcept C138816342 @default.
• W1964361983 hasConcept C142724271 @default.
• W1964361983 hasConcept C187212893 @default.
• W1964361983 hasConcept C23131810 @default.
• W1964361983 hasConcept C2777025531 @default.
• W1964361983 hasConcept C2777107064 @default.
• W1964361983 hasConcept C2777768864 @default.
• W1964361983 hasConcept C2777975735 @default.
• W1964361983 hasConcept C2781069245 @default.
• W1964361983 hasConcept C2908628106 @default.
• W1964361983 hasConcept C2909923361 @default.
• W1964361983 hasConcept C71924100 @default.
• W1964361983 hasConceptScore W1964361983C126322002 @default.
• W1964361983 hasConceptScore W1964361983C138816342 @default.
• W1964361983 hasConceptScore W1964361983C142724271 @default.
• W1964361983 hasConceptScore W1964361983C187212893 @default.
• W1964361983 hasConceptScore W1964361983C23131810 @default.
• W1964361983 hasConceptScore W1964361983C2777025531 @default.
• W1964361983 hasConceptScore W1964361983C2777107064 @default.
• W1964361983 hasConceptScore W1964361983C2777768864 @default.
• W1964361983 hasConceptScore W1964361983C2777975735 @default.
• W1964361983 hasConceptScore W1964361983C2781069245 @default.
• W1964361983 hasConceptScore W1964361983C2908628106 @default.
• W1964361983 hasConceptScore W1964361983C2909923361 @default.
• W1964361983 hasConceptScore W1964361983C71924100 @default.
• W1964361983 hasIssue "8" @default.
• W1964361983 hasLocation W19643619831 @default.
• W1964361983 hasLocation W19643619832 @default.
• W1964361983 hasLocation W19643619833 @default.
• W1964361983 hasLocation W19643619834 @default.
• W1964361983 hasOpenAccess W1964361983 @default.

• next